User profiles for M K Gibson

Molly Gibson

Flagship Pioneering
Verified email at flagshippioneering.com
Cited by 6480

Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology

…, P Fanta, F Farjah, H Gerdes, MK Gibson… - Journal of the National …, 2022 - jnccn.org
Gastric cancer is the third leading cause of cancer-related deaths worldwide. Over 95% of
gastric cancers are adenocarcinomas, which are typically classified based on anatomic …

[HTML][HTML] Oesophageal carcinoma

A Pennathur, MK Gibson, BA Jobe, JD Luketich - The Lancet, 2013 - thelancet.com
Oesophageal carcinoma affects more than 450 000 people worldwide and the incidence is
rapidly increasing. Squamous-cell carcinoma is the predominant form of oesophageal …

Bacterial phylogeny structures soil resistomes across habitats

KJ Forsberg, S Patel, MK Gibson, CL Lauber, R Knight… - Nature, 2014 - nature.com
Ancient and diverse antibiotic resistance genes (ARGs) have previously been identified
from soil 1 , 2 , 3 , including genes identical to those in human pathogens 4 . Despite the …

Longitudinal analysis of microbial interaction between humans and the indoor environment

…, W Van Treuren, NA Hasan, MK Gibson… - Science, 2014 - science.org
The bacteria that colonize humans and our built environments have the potential to influence
our health. Microbial communities associated with seven families and their homes over 6 …

Improved annotation of antibiotic resistance determinants reveals microbial resistomes cluster by ecology

MK Gibson, KJ Forsberg, G Dantas - The ISME journal, 2015 - academic.oup.com
Antibiotic resistance is a dire clinical problem with important ecological dimensions. While
antibiotic resistance in human pathogens continues to rise at alarming rates, the impact of …

[HTML][HTML] Pembrolizumab for platinum-and cetuximab-refractory head and neck cancer: results from a single-arm, phase II study

…, L Wirth, A Sukari, H Kang, MK Gibson… - Journal of Clinical …, 2017 - ncbi.nlm.nih.gov
Purpose There are no approved treatments for recurrent/metastatic head and neck squamous
cell carcinoma refractory to platinum and cetuximab. In the single-arm, phase II KEYNOTE-…

Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the …

MK Gibson, Y Li, B Murphy, MHA Hussain… - Journal of Clinical …, 2005 - ascopubs.org
Purpose To determine the response rate, survival and toxicity of infusional cisplatin plus
fluorouracil (CF) versus cisplatin plus paclitaxel (CP) in patients with incurable squamous cell …

Developmental dynamics of the preterm infant gut microbiota and antibiotic resistome

MK Gibson, B Wang, S Ahmadi, CAD Burnham… - Nature …, 2016 - nature.com
Abstract Development of the preterm infant gut microbiota is emerging as a critical research
priority 1. Since preterm infants almost universally receive early and often extended …

Abrogation of p53-induced apoptosis by the hepatitis B virus X gene

XW Wang, MK Gibson, W Vermeulen, H Yeh… - Cancer research, 1995 - AACR
The p53 tumor suppressor gene product is a transcriptional transactivator and a potent
apoptotic inducer. The fact that many of the DNA tumor virus oncoproteins bind to p53 and affect …

Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy

…, PF Ferson, WE Gooding, MK Gibson… - The Annals of thoracic …, 2009 - Elsevier
OBJECTIVES: Esophagectomy is the standard treatment for T1 esophageal cancer (EC).
Interest in endoscopic therapies, particularly for T1 EC, is increasing. We evaluated the long-…